Antithrombotic therapy in patients with COVID-19?-Rationale and Evidence
…, N Mancini, E Fominskiy, A Margonato… - International journal of …, 2021 - Elsevier
In patients with severe or critical Coronavirus disease 2019 (COVID-19) manifestations, a
thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly …
thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly …
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis
Objectives Differences in terms of safety and efficacy of percutaneous edge-to-edge mitral
repair between patients with functional and degenerative mitral regurgitation (MR) are not …
repair between patients with functional and degenerative mitral regurgitation (MR) are not …
Ischemic mitral regurgitation: mechanisms and echocardiographic classification
…, A Meris, F Maisano, A Margonato - European Journal of …, 2008 - academic.oup.com
Chronic ischemic mitral regurgitation (IMR) is a common complication of myocardial
infarction and severely affects cardiovascular mortality and morbidity. Multiple …
infarction and severely affects cardiovascular mortality and morbidity. Multiple …
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented …
…, A Briganti, A Salonia, P Rigatti, A Margonato… - European urology, 2003 - Elsevier
Objectives: The aim of this study was to assess erectile dysfunction prevalence, time of onset
and association with risk factors in patients with acute chest pain and angiographically …
and association with risk factors in patients with acute chest pain and angiographically …
Valsartan for prevention of recurrent atrial fibrillation
…, D Cuzzucrea, G Gentile, A Margonato… - New England Journal …, 2009 - air.unimi.it
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
…, G Calori, A Del Maschio, A Margonato - European heart …, 2006 - academic.oup.com
Aims The addition of trimetazidine to standard treatment has been shown to improve left
ventricular (LV) function in patients with heart failure. The aim of this study is to non …
ventricular (LV) function in patients with heart failure. The aim of this study is to non …
“Ultrasound comet-tail images”: a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water
…, M Oppizzi, G Marino, A Zangrillo, A Margonato… - Chest, 2005 - Elsevier
Background Echographic examination of the lung surface may reveal multiple “comet-tail
images” originating from water-thickened interlobular septa. These images could be useful …
images” originating from water-thickened interlobular septa. These images could be useful …
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure
…, M Pala, G Calori, O Alfieri, A Margonato - Journal of the American …, 2006 - jacc.org
Objectives: This study sought to assess whether the long-term addition of trimetazidine to
conventional treatment could improve functional class, exercise tolerance, and left …
conventional treatment could improve functional class, exercise tolerance, and left …
Short-and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy
…, P Puccetti, G Calori, GD Lopaschuk, A Margonato - American heart …, 2003 - Elsevier
BACKGROUND: Trimetazidine (TMZ) has been shown to partially inhibit free fatty acid
oxidation by shifting substrate utilization from fatty acid to glucose. The aim of this study was …
oxidation by shifting substrate utilization from fatty acid to glucose. The aim of this study was …
Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting
…, C Ronchi, A Origgi, I Zavaroni, A Margonato… - Circulation, 2003 - Am Heart Assoc
Background—Previously undiagnosed diabetes, impaired glucose tolerance, and insulin
resistance are common in patients with acute myocardial infarction and coronary heart …
resistance are common in patients with acute myocardial infarction and coronary heart …